HLA‐G promotes myeloid‐derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Establishing and maintaining maternal‐fetal tolerance is essential for a successful pregnancy; failure of immunological adaptation to pregnancy leads to severe complications such as abortion or preterm delivery. Myeloid‐derived suppressor cells (MDSCs) are innate immune cells that suppress T‐cell responses, expand during pregnancy and thus may play a role in tolerance induction. Human leucocyte antigen G (HLA‐G) is a major histocompatibility complex (MHC) I molecule with immune‐modulatory properties, which is expressed during pregnancy. Here, we investigated the impact of HLA‐G on MDSCs accumulation and activation in pregnant women. We demonstrate that granulocytic MDSCs (GR‐MDSCs) express receptors for HLA‐G, namely immunoglobulin‐like transcript (ILT) 2 and 4, and that ILT4‐expression by GR‐MDSCs is regulated during pregnancy. Stimulation with soluble HLA‐G (sHLA‐G) increased suppressive activity of GR‐MDSCs, induced MDSCs from peripheral blood mononuclear cells (PBMCs) and led to phosphorylation of the signal transducer and activator of transcription 3 (STAT3) and induction of indoleamine‐2,3‐dioxygenase (IDO) in myeloid cells. Effects of sHLA‐G on MDSC accumulation were mediated through ILT4. These results suggest an interaction between MDSCs and HLA‐G in humans as a potential mechanism for maintaining maternal‐fetal tolerance. Modulating MDSC function during pregnancy via HLA‐G might provide new opportunities for a therapeutic manipulation of immunological pregnancy complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rai, R., & Regan, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69204-0 · Cited by 1,227
Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer
Nefedova, Y., Huang, M., Kusmartsev, S., Bhattacharya, R., Cheng, P., Salup, R., Jove, R., & Gabrilovich, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.464 · Cited by 464
Zoso, A., Mazza, E. M. C., Bicciato, S., Mandruzzato, S., Bronte, V., Serafini, P., & Inverardi, L. (2014) · European Journal of Immunology · doi:10.1002/eji.201444522 · Cited by 123
Cited by
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
Huang, Y.-S., Ogbechi, J., Clanchy, F. I., Williams, R. O., & Stone, T. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00388 · Cited by 187
“HLA-G has been associated primarily with materno-fetal tolerance (106) but elevated HLA-G expression has been noted in several CNS disorders in which its effects are largely immunesuppressant (107, 108).”
BackgroundHuman leukocyte immunoglobulin-like receptors in health and disease
Redondo-García, S., Barritt, C., Papagregoriou, C., Yeboah, M., Frendeus, B., Cragg, M. S., & Roghanian, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1282874 · Cited by 53
Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer
Deng, M., Chen, H., Liu, X., Huang, R., He, Y., Yoo, B., Xie, J., John, S., Zhang, N., An, Z., et al. (2021) · Antibody Therapeutics · doi:10.1093/abt/tbab002 · Cited by 53
Metadata
- Authors
- Köstlin, N., Ostermeir, A., Spring, B., Schwarz, J., Marmé, A., Walter, C. B., Poets, C. F., & Gille, C.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2016-12-09
- Volume
- 47
- Issue
- 2
- Pages
- 374-384
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2549171424
- Cited by
- 93
- References
- 3
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.